What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Enzyme
His primary areas of study are Positron emission tomography, Pathology, Nuclear medicine, In vivo and Integrin.
His Positron emission tomography study is concerned with Radiology in general.
His Pathology study combines topics in areas such as Fluorodeoxyglucose, Cancer and Beta.
The concepts of his Nuclear medicine study are interwoven with issues in Pharmacokinetics, Head and neck cancer, Hypoxia and Biodistribution.
He has included themes like Cancer research, In vitro, Peptide, Biochemistry and Molecular biology in his In vivo study.
His Integrin research is multidisciplinary, incorporating elements of Angiogenesis, Renal cell carcinoma, Cell adhesion, Cell biology and Pet imaging.
His most cited work include:
- Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy (690 citations)
- Noninvasive Imaging of αvβ3 Integrin Expression Using 18F-labeled RGD-containing Glycopeptide and Positron Emission Tomography (544 citations)
- Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer (423 citations)
What are the main themes of his work throughout his whole career to date?
Hans-Jürgen Wester mainly investigates Positron emission tomography, In vivo, Pathology, Nuclear medicine and Biodistribution.
His Positron emission tomography research focuses on subjects like Prostate cancer, which are linked to Lymph node.
His In vivo research includes elements of Receptor, Molecular biology, In vitro and Stereochemistry.
His study on Pathology also encompasses disciplines like
- CXCR4 that connect with fields like Cancer research,
- Angiogenesis which is related to area like Metastasis.
His study on PET-CT and Dosimetry is often connected to In patient as part of broader study in Nuclear medicine.
His Biodistribution study combines topics from a wide range of disciplines, such as Pharmacokinetics, LNCaP, Lipophilicity and Radioligand.
He most often published in these fields:
- Positron emission tomography (28.16%)
- In vivo (23.42%)
- Pathology (23.68%)
What were the highlights of his more recent work (between 2016-2021)?
- Prostate cancer (13.95%)
- Positron emission tomography (28.16%)
- CXCR4 (12.63%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Prostate cancer, Positron emission tomography, CXCR4, In vivo and PET-CT.
His biological study spans a wide range of topics, including Lymph node and Urology.
His Positron emission tomography research is multidisciplinary, incorporating perspectives in Internal medicine, Malignancy, Oncology, Molecular imaging and Magnetic resonance imaging.
His CXCR4 research includes themes of Immunohistochemistry, Pathology, Cancer research and Chemokine receptor.
Hans-Jürgen Wester specializes in In vivo, namely Biodistribution.
Hans-Jürgen Wester combines subjects such as Integrin and Peptide with his study of Molecular biology.
Between 2016 and 2021, his most popular works were:
- A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins. (183 citations)
- Exploring the Role of RGD-Recognizing Integrins in Cancer. (148 citations)
- Preclinical evaluation and first patient application of 99mTc-PSMA-I&S for SPECT imaging and radioguided surgery in prostate cancer (76 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Enzyme
His primary areas of investigation include Prostate cancer, Positron emission tomography, PET-CT, CXCR4 and Biochemical recurrence.
His studies in Prostate cancer integrate themes in fields like Radiology, Radiation therapy and Oncology.
Hans-Jürgen Wester has researched Positron emission tomography in several fields, including Neuroendocrine tumors, Recurrent prostate cancer and Somatostatin receptor.
His PET-CT study introduces a deeper knowledge of Nuclear medicine.
The various areas that Hans-Jürgen Wester examines in his CXCR4 study include Cancer research, Chemokine receptor and Pathology.
His studies deal with areas such as Biodistribution, In vivo, Neuroscience and Review article as well as Receptor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
